We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BELA:ATHEXJumbo S.A. Analysis

Data as of 2026-06-12 - not real-time

€22.62

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Jumbo S.A. (BELA) trades at €22.62, roughly 36% below its DCF‑derived fair value of €28.58, indicating a clear undervalued position. The company boasts a low trailing P/E of 9.5, a forward P/E of 8.2, and a solid dividend yield of 2.25% with a modest payout ratio of 21%, underscoring sustainable cash generation. Fundamental metrics are robust: revenue growth of 6.7%, gross margin of 54%, operating margin of 35%, and ROE of 21%, while the balance sheet shows ample cash (€536 m) versus modest debt (€66 m).
On the technical side, the stock sits just above its support at €21.40 and below resistance at €23.74, with the 20‑day SMA (22.58) providing a slight cushion. RSI is neutral at 48.6 and the MACD histogram is positive, signaling a tentative bullish shift despite an overall bearish trend. Volatility remains high at 26% over the past month, but the low beta of 0.42 suggests limited market‑wide risk, and the current market sentiment is in the “Extreme Greed” zone (89.86).

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • DCF upside of ~36% suggests price appreciation potential
  • Price near technical support with bullish MACD histogram
  • Low beta mitigates market volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong operating margins and ROE indicate durable profitability
  • Sustainable dividend yield of 2.25% with low payout ratio
  • Continued revenue growth and cash generation support earnings expansion

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Fundamental undervaluation relative to DCF fair value
  • Robust balance sheet with high cash and low net debt
  • Stable dividend policy and favorable long‑term industry outlook

Key Metrics & Analysis

Financial Health

Revenue Growth6.70%
Profit Margin25.98%
P/E Ratio9.5
ROE21.46%
ROA13.70%
Debt/Equity4.22
P/B Ratio1.9
Op. Cash Flow€296.9M
Free Cash Flow€191.3M

Technical Analysis

TrendBearish
RSI48.6
Support€21.40
Resistance€23.74
MA 20€22.58
MA 50€22.84
MA 200€26.28
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value€28.58
Target Price€30.84
Upside/Downside36.33%
GradeUndervalued
TypeBlend
Dividend Yield2.25%

Risk Assessment

Beta0.42
Volatility26.11%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.